[Predictive factors for response to chemotherapy in breast cancers].
Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine.
Yasuo
Y
Miyoshi
Shinzaburo
S
Noguchi
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018943:Anthracyclines / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D064127:Aurora Kinases; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System; D004250:DNA Topoisomerases, Type II; D004268:DNA-Binding Proteins; D005260:Female; D005544:Forecasting; D006801:Humans; D011110:Polymorphism, Genetic; D017346:Protein Serine-Threonine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D043823:Taxoids / Q000627:therapeutic use*; D014404:Tubulin
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D064127:Aurora Kinases; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System; D004250:DNA Topoisomerases, Type II; D004268:DNA-Binding Proteins; D017346:Protein Serine-Threonine Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D043823:Taxoids; D014404:Tubulin; C510163:CYP3A4 protein, human